Margaret has more than twenty five years of experience in the development and manufacture of active substances and drug products.
Margaret joined Lamellar in July 2016. She is responsible for product development and manufacture including the oversight of contract manufacturers and management of academic collaborations. Prior to Lamellar, she was at Vernalis (R&D) Ltd for more than fourteen years. As Director of Pharmaceutical Quality Operations, Margaret was responsible for the formulation and process development of NCEs and biologics in clinical development as well as the manufacture of commercial products. Margaret’s team managed the development of multiple drug products, including complex modified release formulations, in addition to preparing the CMC and non-clinical sections of regulatory submissions.
Before joining Vernalis, Margaret was Assistant Director, Oral Healthcare at GlaxoSmithKline from 1999 to 2002, where she managed key research programmes and exploratory clinical studies as well as identifying and evaluating new technologies. Margaret started her industrial career at a drug delivery technology company, Core Technologies, where she had a key role in the development of the lead product along with building the formulation development and clinical trial supplies teams.
Margaret has a BSc in Pharmacy from the University of Strathclyde where she subsequently completed a PhD and two year post-doctoral fellowship focussed on the development of a polymeric modified release system. She is also a registered pharmacist.